In the present study, we tested the hypothesis that platelet-derived growth factor receptor-alpha (PDGFRα) is a key molecular target for DHA as a selective anti-PDGFRα-positive ovarian cancer agent. This evidence concerns the gene PDGFRA and ovarian cancer.